P
Palisade Bio, Inc. (PALI)
NCM – Real vaqt narxi. Valyuta: USD
1.89
+0.09 (5.00%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.89
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 6:56 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.89
+0.09 (5.00%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.89
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 6:56 PM EDT
| Tarkibi | |
|---|---|
| 1.64% | Insayderlar egalik qilgan aksiyalar ulushi |
| 93.76% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 95.32% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 108 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| B Group, Inc. | 11.41M | 2026-03-31 | 6.58% | $20.32M |
| Janus Henderson Group PLC | 10.69M | 2026-03-31 | 6.16% | $19.03M |
| Octagon Capital Advisors LP | 10.28M | 2026-03-31 | 5.92% | $18.29M |
| Perceptive Advisors Llc | 8.93M | 2026-03-31 | 5.14% | $15.89M |
| Ameriprise Financial, Inc. | 8.71M | 2026-03-31 | 5.02% | $15.51M |
| Commodore Capital Lp | 7.18M | 2026-03-31 | 4.14% | $12.78M |
| RA Capital Management, L.P. | 7.12M | 2026-03-31 | 4.10% | $12.68M |
| Franklin Resources, Inc. | 5.79M | 2026-03-31 | 3.33% | $10.30M |
| Goldman Sachs Group Inc | 5.37M | 2026-03-31 | 3.10% | $9.57M |
| Eversept Partners, LP | 4.99M | 2026-03-31 | 2.87% | $8.88M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 2.42M | 2026-01-31 | 1.40% | $4.31M |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 2.12M | 2026-01-31 | 1.22% | $3.77M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.43M | 2026-03-31 | 0.82% | $2.54M |
| T. Rowe Price Health Sciences Fund, Inc. | 1.24M | 2025-12-31 | 0.72% | $2.16M |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 688,066 | 2026-04-30 | 0.40% | $1.22M |
| abrdn Life Sciences Investors | 662,900 | 2026-03-31 | 0.38% | $1.18M |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 375,558 | 2026-04-30 | 0.22% | $668,493.00 |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 350,000 | 2026-03-31 | 0.20% | $622,999.00 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 269,212 | 2026-04-30 | 0.16% | $479,197.00 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 204,340 | 2026-04-30 | 0.12% | $363,725.00 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 99,684 | 2026-04-30 | 0.06% | $177,437.00 |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 90,454 | 2025-12-31 | 0.05% | $190,405.00 |
| T. ROWE PRICE Eqy. SERIES, INC.-T. Rowe Price Health Sciences PORT. | 74,955 | 2025-12-31 | 0.04% | $149,160.00 |
| Virtus Investment Trust-Virtus Small-Cap Fund | 46,000 | 2025-12-31 | 0.03% | $81,189.00 |
| John Hancock Variable Insurance Trust-Health Sciences Trust | 27,162 | 2025-12-31 | 0.02% | $46,175.00 |
| EQ Advisors Trust-EQ/T. Rowe Price Health Sciences Portfolio | 19,516 | 2025-12-31 | 0.01% | $35,616.00 |